- ABOUT AERAS
- ABOUT TB & VACCINES
- OUR APPROACH
Global Efforts to Fight TB
Organizations of all types — public, private, academic, health care, governmental and charitable, as well as biotech and pharmaceutical companies — have become increasingly involved in the fight against TB. Controlling and eventually eliminating tuberculosis as a public health threat is a global effort that requires a global commitment. To achieve this goal, there must be both investment in and support for implementation of current TB control strategies, as well as research and development of new tools to combat the disease. These include vaccines, drugs and diagnostics.
Click below to jump down the page to a particular section:
Stop TB Partnership Publications
The Global Plan to Stop TB 2011-2015
The latest update to the Stop TB Partnership's Global Plan to Stop TB 2011-2015.
> find out more
World Health Organization's Stop TB StrategyEfforts to eliminate TB generally fall within this strategy:
Stop TB Department, World Health Organization
The Stop TB Department at the World Health Organization (WHO) provides leadership in strategic and technical aspects of TB control worldwide, in order to reverse the epidemic and eventually eliminate TB.
The WHO also compiles data on TB incidence, prevalence and trends, which it releases in an annual Global Tuberculosis Control Report.
The Stop TB PartnershipIn 2006, the Stop TB Partnership launched the Global Plan to Stop TB 2006-2015 and revised the plan in 2010 when it published The Global Plan to Stop TB 2011-2016. It outlines the actions and funding needed to reach the public health targets for achieving United Nations Millennium Development Goal (MDG). The primary goal is the elimination of TB as a public health threat (less than one case per million) by 2050.
Product Development PartnershipsA Product Development Partnership (PDP) is a non-profit organization that builds partnerships between the public, private, academic and philanthropic sectors to drive the development of new products for under-served markets. Through their unique collaborative efforts, PDPs are able to access a diversity of funding sources and to apply a wide range of tools and knowledge to their programs.
There are three PDPs working specifically to develop new tools for tuberculosis: